Neuropeptide Y improves cisplatin-induced bone marrow dysfunction without blocking chemotherapeutic efficacy in a cancer mouse model

키워드

참고문헌 (29)

1. Blanchard EM, "Cisplatin and solid tumours: still working, after all these years", J Solid Tumors, 2, pp.26~33 (2012)
2. Siddik ZH, "Cisplatin: mode of cytotoxic action and molecular basis of resistance", Oncogene, 22, pp.7265~7279 (2003)
3. Wang D, "Cellular processing of platinum anticancer drugs", Nat Rev Drug Discov, 4, pp.307~320 (2005)
4. Cepeda V, "Biochemical mechanisms of cisplatin cytotoxicity", Anticancer Agents Med Chem, 7, pp.3~18 (2007)
5. Einhorn LH, "Curing metastatic testicular cancer", Proc Natl Acad Sci U S A, 99, pp.4592~4595 (2002)
6. Armstrong DK, "A phase I study of paclitaxel, topotecan, cisplatin and filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study", Gynecol Oncol, 105, pp.667~671 (2007)
7. Ridwelski K, "Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer", Ann Oncol, 12, pp.47~51 (2001)
8. Cullen KJ, "Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer", J Bioenerg Biomembr, 39, pp.43~50 (2007)
9. Niell HB, "Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732", J Clin Oncol, 23, pp.3752~3759 (2005)
10. Chaudhry V, "Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies", Ann Neurol, 35, pp.304~311 (1994)
11. Pabla N, "Inhibition of PKC reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer", J Clin Invest, 121, pp.2709~2722 (2011)
12. Hatzopoulos S, "Evaluation of cisplatin ototoxicity in a rat animal model", Ann NY Acad Sci, 884, pp.211~225 (1999)
13. Noach EJ, "Chemotherapy prior to autologous bone marrow transplantation impairs long-term engraftment in mice", Exp Hematol, 28, pp.1325~1333 (2000)
14. Banfi A, "High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia", Cancer, 92, pp.2419~2428 (2001)
15. Lucas D, "Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration", Nat Med, 19, pp.695~703 (2013)
16. Zukowska-Grojec Z, "Neuropeptide Y. A novel sympathetic stress hormone and more", Ann NY Acad Sci, 771, pp.219~233 (1995)
17. Kalra SP, "NPY and cohorts in regulation appetite, obesity and metabolic syndrome: beneficial effects of gene therapy", Neuropeptides, 38, pp.201~211 (2004)
18. Kuo LE, "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome", Nat Med, 13, pp.803~811 (2007)
19. Santos-Carvalho A, "Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate", Cell Death Dis, 4, pp.e636~ (2013)
20. Park MH, "Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow", EMBO J, 34, pp.1648~1660 (2015)
21. 박민희, "Role of neuropeptide Y in the bone marrow hematopoietic stem cell microenvironment", BMB Reports, 48(12), pp.645~646 (2015), 생화학분자생물학회
22. Can A, "Haematopoietic stem cells niches: Interrelations between structure and function", Transfus Apher Sci, 38, pp.261~268 (2008)
23. Butler JM, "Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells", Cell Stem Cell, 6, pp.251~264 (2010)
24. Robinson SN, "Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34+, CD34+38− and week-6 CAFC assays predict poor engraftment", Exp Hematol, 28, pp.1325~1333 (2000)
25. Perseghin P, "Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions", Transfus Apher Sci, 41, pp.33~37 (2009)
26. Park MH, "Neuropeptide Y Induces Hematopoietic Stem", Progenitor Cell Mobilization by Regulating Matrix Metalloproteinase-9 Activity through Y1 Receptor in Osteoblasts, 2016, pp.34, 2145~2156
27. 김남오, "Neuropeptide Y protects kidney against cisplatin-induced nephrotoxicity by regulating p53-dependent apoptosis pathway", BMB Reports, 49(5), pp.288~292 (2016), 생화학분자생물학회
28. Aloe L, "Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis", Auton Neurosci, 86, pp.84~93 (2000)
29. Kawamoto T, "Use of a new adhesive film for the preparation of multipurpose fresh-frozen sections from hard tissues, whole-animals, insects and plants", Arch Histol Cytol, 66, pp.123~143 (2003)

관련 논문AI추천